NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs061210050

Registered date:18/11/2021

Safety assessment of 20 mL intrathecal injection in CSF refill test

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedcerebrospinal fluid hypovolemia
Date of first enrollment18/11/2021
Target sample size15
Countries of recruitment
Study typeInterventional
Intervention(s)In the CSF refill test, we evaluate the pain by standing and measure the time of walking 10m before the CSF refill test. Then, lumbar puncture is performed by a general lumbar puncture method to confirm that the cerebrospinal fluid pressure is 100 mmH2O or less, and then 20 mL of ARTCEREB is intramedullarily injected. The final pressure is alsomeasured after full injection. If the intermediate pressure is 200 mmH2O or more, the injection is stopped at that point and the injection is terminated.Regardless of whether the injection is interruptedor completed, the walking time of 10 m is measured after the injection is completed, and the pain in the standing position is evaluated(VAS) . After that, rest in a lying position for 1 hour, and then confirm adverse events. About one week before and after that, a medical examination or contact will be made to confirm adverse events. And the study will be completed.

Outcome(s)

Primary OutcomeWe examine the safety of the CSF refill test by assessing adverse events before and after injecting 20 mL of ARTCEREB.
Secondary Outcome1. We measure the initial, intermediate and final pressures of cerebrospinal fluid during lumbar puncture. 2. We evaluate the VAS score before and after ARTCEREB intrathecal injection. 3. We measure the time to walk 10 m before and after intrathecal injection.

Key inclusion & exclusion criteria

Age minimum>= 18age old
Age maximumNot applicable
GenderBoth
Include criteriaPatients who meet all of the following criteria are targeted. 1. Patients with overt orthostatic headache and suspected cerebrospinal fluid hypovolemia 2. Patients with CSF pressure of 100mmH2O or less 3. Patients over 18 years old 4. Patients who have given written consent to participate in this study(If you are a minor or you do not have the ability to consent, you will be a substitute)
Exclude criteriaPatients who fall under any of the following are excluded. 1. Patients who tend to bleed 2. Patients who have difficulty with lumbar puncture 3. Pregnant woman 4. Patients recognized by doctors ineligible

Related Information

Contact

Public contact
Name Eiichi Nakai
Address Kohasu 185-1, Oko-cho, Nankoku-Shi, Kochi, Japan Kouchi Japan 783-8505
Telephone +81-88-880-2397
E-mail enakai@kochi-u.ac.jp
Affiliation Kochi Medical School Hospital
Scientific contact
Name Eiichi Nakai
Address Kohasu 185-1, Oko-cho, Nankoku-Shi, Kochi, Japan Kouchi Japan 783-8505
Telephone +81-88-880-2397
E-mail enakai@kochi-u.ac.jp
Affiliation Kochi Medical School Hospital